We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

139 hedge funds and large institutions have $2.33B invested in Legend Biotech in 2021 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 44 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

371% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 14

91% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 23

58% more funds holding

Funds holding: 88 → 139 (+51)

18% more capital invested

Capital invested by funds: $1.97B → $2.33B (+$357M)

2.95% more ownership

Funds ownership: 13.48% → 16.43% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

53% less call options, than puts

Call options by funds: $2.89M | Put options by funds: $6.1M

Holders
139
Holders Change
+51
Holders Change %
+57.95%
% of All Funds
2.14%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
66
Increased
44
Reduced
23
Closed
14
Calls
$2.89M
Puts
$6.1M
Net Calls
-$3.21M
Net Calls Change
-$3.6M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$85.4M
2
BlackRock
BlackRock
New York
+$79.6M
3
Artisan Partners
Artisan Partners
Wisconsin
+$40.6M
4
HA
HHLR Advisors
Cayman Islands
+$38M
5
State Street
State Street
Massachusetts
+$27.5M

Top Sellers

1
MICM
Matthews International Capital Management
California
-$17.8M
2
VC
Vivo Capital
California
-$12.4M
3
APM
Avidity Partners Management
Texas
-$9.24M
4
AA
ALPS Advisors
Colorado
-$8.96M
5
Citadel Advisors
Citadel Advisors
Florida
-$7.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
DekaBank Deutsche Girozentrale
101
DekaBank Deutsche Girozentrale
Germany
$417K +$144K +2,835 +47%
EFM
102
E Fund Management
China
$416K +$453K +8,927 New
EFMH
103
E Fund Management (HK)
Hong Kong
$416K +$453K +8,927 New
N
104
Natixis
France
$377K +$34.8K +686 +9%
Victory Capital Management
105
Victory Capital Management
Texas
$377K +$410K +8,086 New
TC
106
TwinBeech Capital
New York
$373K +$406K +8,012 New
Caisse de Depot et Placement du Quebec (CDPQ)
107
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$368K +$401K +7,900 New
SAM
108
Sectoral Asset Management
Quebec, Canada
$326K -$20.3K -400 -5%
LSA
109
Leonteq Securities AG
Switzerland
$325K +$353K +6,966 New
ProShare Advisors
110
ProShare Advisors
Maryland
$292K -$28.4K -559 -8%
TI
111
Trexquant Investment
Connecticut
$287K -$417K -8,212 -57%
Two Sigma Advisers
112
Two Sigma Advisers
New York
$252K +$274K +5,400 New
EAMA
113
EFG Asset Management (Americas)
Florida
$234K +$254K +5,011 New
VOYA Investment Management
114
VOYA Investment Management
Georgia
$219K +$238K +4,697 New
Nomura Asset Management
115
Nomura Asset Management
Japan
$210K +$228K +4,500 New
IBT
116
International Biotechnology Trust
United Kingdom
$209K -$2.28M -45,000 -91%
State of Wisconsin Investment Board
117
State of Wisconsin Investment Board
Wisconsin
$207K +$225K +4,439 New
VEA
118
Virtus ETF Advisers
New York
$158K -$95.4K -1,881 -36%
AA
119
AlphaCentric Advisors
Puerto Rico
$140K +$152K +3,000 New
Daiwa Securities Group
120
Daiwa Securities Group
Japan
$126K +$131K +2,587 +2,373%
Macquarie Group
121
Macquarie Group
Australia
$126K +$134K +2,638 +3,937%
Ensign Peak Advisors
122
Ensign Peak Advisors
Utah
$89K +$96.4K +1,900 New
Wells Fargo
123
Wells Fargo
California
$62K +$67.9K +1,338 New
Rockefeller Capital Management
124
Rockefeller Capital Management
New York
$46K -$25.4K -500 -33%
National Pension Service
125
National Pension Service
South Korea
$44K +$47.9K +944 New
3 4
5
6 7

LEGN Hedge Fund Activity: Q4 2021 in Review

139 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q4 2021, worth a combined $2.33B — up 18% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 66 funds opened new LEGN positions and 14 closed out — a net gain of 52 holders — while 44 added to existing stakes and 23 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $85.4M. The largest seller was Matthews International Capital Management, cutting an estimated $17.8M.

  • 139 institutional investors held Legend Biotech (LEGN) as of Q4 2021, up from 88 in Q3 2021.
  • Funds reported $2.33B of Legend Biotech stock for Q4 2021, up 18% quarter-over-quarter.
  • 66 funds opened new Legend Biotech positions in Q4 2021 and 14 closed out, a net change of +52 holders.
  • The largest Legend Biotech buyer in Q4 2021 was Wellington Management Group, an estimated $85.4M added.
  • The largest Legend Biotech seller in Q4 2021 was Matthews International Capital Management, an estimated $17.8M sold.

Based on aggregated 13F filings for Q4 2021.